MAPT and Schnyder corneal dystrophy: However, to better validate the SCD criteria and fully understand the impact of these pathophysiologic biomarkers on SCD progression, a replication study incorporating amyloid and tau status, as well as APOE ε4 genotype information and follow‐up data, would be necessary.